SUBSCRIBE
SUBSCRIBE
News   Policy

Dr. Reddy’s Laboratories Ltd.'s Announces Settlement Of Imitrex® Litigation With GlaxoSmithKline

October 10, 2006 | 
1 min read
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE:RDY) announced today that it has settled patent litigation with GlaxoSmithKline relating to sumatriptan succinate tablets, the generic version of GlaxoSmithKline’s Imitrex® tablets.
Legal Asia
GlaxoSmithKline
MORE ON THIS TOPIC
Business people shaking hand in China.
Obesity
AstraZeneca’s China Trip Yields CSPC Obesity Deal Worth $1.2B Upfront
January 30, 2026
 · 
2 min read
 · 
Tristan Manalac
Facade of AstraZeneca's office in Shanghai, China
China
AstraZeneca Pledges $15B More in Chinese Investments for Cell Therapies, Radiopharma
January 29, 2026
 · 
1 min read
 · 
Tristan Manalac
Sunset skyline of San Diego downtown viewed from Coronado Island.
gene therapy
Advanced Therapies Week 2026: ‘Solving for Science’ and Weathering Global Complexity
January 28, 2026
 · 
4 min read
 · 
Heather McKenzie
Composite contemporary collage statue of justice themis femida on the background of the target as the concept and idea of justice and law. High quality photo
Legal
CytoDyn’s Former CEO Gets Jail Time, $5.3M+ Fine for Securities Fraud
January 27, 2026
 · 
2 min read
 · 
Tristan Manalac